Celgene Officially Notified Of ANDA Filing For REVLIMID(R)
Celgene Corporation (NASDAQ:Ã�CELG) announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA). The application requests authorization to manufacture and market generic versions of REVLIMID® (lenalidomide) 5, 10, 15 and 25 mg capsules in the United States... (Source: Health News from Medical News Today)
Video: Return to School-Year Sleep Schedules
Your regular sleep habits may have been disrupted over the summer by vacation travel, and your kids may have forgotten what it's like to wake up early for class. Dr. Jennifer Ashton spoke with Erica Hill about how to help everyone back to their pre-summer sleep routines. (Source: Health News: CBSNews.com)
